In conclusion, our study demonstrates in the initial treatment plan for advanced ovarian cancer patients, the diagnostic accuracy of age, preoperative serum CA125 level and preoperative serum HE4 level in assessing optimal surgical cytoreduction should be considered. This evidence concerns the gene WFDC2 and ovarian cancer.